Catalogo dei prodotti della ricerca

AVERSA, ZAIRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.409
EU - Europa 257
AS - Asia 239
SA - Sud America 9
AF - Africa 7
OC - Oceania 2
Totale 1.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.403
CN - Cina 96
IN - India 80
IT - Italia 78
SG - Singapore 62
FI - Finlandia 56
UA - Ucraina 36
SE - Svezia 27
DE - Germania 18
GB - Regno Unito 15
RU - Federazione Russa 10
IE - Irlanda 9
AR - Argentina 6
CA - Canada 5
ZA - Sudafrica 5
BE - Belgio 3
RO - Romania 3
BJ - Benin 2
CL - Cile 2
NZ - Nuova Zelanda 2
AT - Austria 1
BG - Bulgaria 1
MX - Messico 1
PE - Perù 1
SA - Arabia Saudita 1
Totale 1.923
Salva come PNG Salva come JPEG
Città #
Fairfield 239
Woodbridge 128
Chandler 106
Santa Clara 99
Houston 94
Ashburn 87
Wilmington 84
Seattle 83
Beijing 75
Cambridge 72
Plano 40
Princeton 40
Ann Arbor 36
Rome 33
Singapore 30
San Paolo di Civitate 24
Millbury 23
Lawrence 20
San Diego 19
Boston 17
Andover 15
Helsinki 15
Jacksonville 15
Dearborn 10
Dublin 9
Falkenstein 9
Federal 6
Moscow 6
San Mateo 6
San Jose 5
Toronto 5
Falls Church 4
Hefei 4
Mannheim 4
Boardman 3
Brussels 3
Frankfurt am Main 3
Muizenberg 3
Norwalk 3
Auburn Hills 2
Fasano 2
Hounslow 2
Jinan 2
Johannesburg 2
London 2
Marino 2
Southwark 2
Turin 2
Wuhan 2
Zhengzhou 2
Albertville 1
Auckland 1
Brandizzo 1
Bühl 1
Callao 1
Chongqing 1
Des Moines 1
Fremont 1
Genova 1
Indiana 1
Lappeenranta 1
Laurel 1
Los Angeles 1
Milan 1
Nanchang 1
Nanjing 1
Provo 1
Redmond 1
Santiago 1
Shijiazhuang 1
Sofia 1
Trento 1
Wellington 1
Westminster 1
Totale 1.523
Salva come PNG Salva come JPEG
Nome #
β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia 84
Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment. 82
Consensus definition of sarcopenia, cachexia and pre-cachexia; joint document elaborated by Special Interest Groups (SIG) “Cachexia-Anorexia in Chronic Wasting Diseases” and “Nutrition in Geriatrics”. 78
Prevention and treatment of cancer cachexia: New insights into an old problem 76
PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting 72
Changes in Myostatin Signaling in Non-Weight-Losing Cancer Patients 70
Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients. 65
C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1. 64
Acetylation and deacetylation--novel factors in muscle wasting. 63
The conundrum of pre-cachexia existence 62
CaMKII activity is reduced in skeletal muscle during sepsis 62
Vitamin D and VDR in cancer cachexia and muscle regeneration 61
Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells. 61
Calpain activity is increased in skeletal muscle from gastric cancer patients with no or minimal weight loss. 60
null 59
Molecules modulating gene transcription during muscle wasting in cancer, sepsis, and other critical illness. 58
Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness 55
Cortisol and the muscle-bone axis 53
β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy 51
null 50
null 50
La nutrizione artificiale nel paziente oncologico 47
Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism. 44
Nutritional support in cancer 43
Livelli sierici di leptina e anoressia in pazienti in trattamento dialitico continuato 39
Statins, Coenzyme Q10, and Cachexia: What's the Link? 37
Attività serino-proteasica muscolare nella cachessia neoplastica sperimentale 35
Beta-hydroxy-beta-methylbutyrate prevents weight and muscle loss in cancer cachexia 31
Molecular mechanisms underlyng muscle loss in patients undergoing liver transplantation 30
Body mass index (BMI) is related to autonomic nervous system activity as measured by heart rate variability (HRV) 30
New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway' 27
Nutritional and metabolic support in hematologic malignancies and hemotopoietic stem cell trasplantation 27
Nuove frontiere della nutrizione clinica nella malattia oncologica 26
Possibilità di impiego della farmaconutrizione 25
L’ espressione genica della miostatina è aumentata dalla presenza di neoplasia 25
Il paziente in emodialisi: anoressia e ghrelina 24
Meccanismi molecolari e massa muscolare in pazienti sottoposti a trapianto di fegato 24
La cachessia neoplastica: conoscerla per prevenirla e contrastarla 23
La somministrazione di idrossi-metil-butirrato previene la perdita di peso e di muscolo in un modello sperimentale di cachessia neoplastica 21
Pharmacological inhibition of the ubiquitin/proteasome ATP-dependent system does not prevent muscle wasting in experimental cancer cachexia 19
Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting 16
Cancer-induced muscle wasting: latest findings in prevention and treatment 12
Autophagy is induced in the skeletal muscle of cachectic cancer patients 11
Totale 1.952
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020280 0 0 0 0 0 0 60 58 49 62 41 10
2020/2021113 14 17 5 17 1 4 0 17 15 9 11 3
2021/2022363 1 32 46 4 59 1 9 37 27 34 26 87
2022/2023314 76 69 7 30 38 31 1 9 36 3 6 8
2023/2024109 11 31 3 5 4 3 1 2 0 20 9 20
2024/2025178 10 0 25 4 63 76 0 0 0 0 0 0
Totale 1.952